Skip to contentP
Phio Pharmaceuticals Corp.
P
PHIOPhio Pharmaceuticals Corp. Q1 2016 · 10-Q
Revenue$10.00K$10.00K−70.6% vs Q1 2015 Net Income-$2.23M-$2.23MN/M vs Q1 2015 EPS Diluted-$3.41-$3.41N/M vs Q1 2015 Operating Income-$2,245,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
Margins · derivedOperating margin-22450.0%−13785.3 pt vs Q1 2015
Net margin-22310.0%−13648.2 pt vs Q1 2015
ended Mar 31, 2016 · filed May 12, 2016 · 42 d after period end